P
Piramal Pharma Ltd
NSE:PPLPHARMA
Piramal Pharma Ltd
NSE:PPLPHARMA
Price:
224.75
INR
2.72%
Market Closed
Market Cap:
296.8B
INR
Balance Sheet
Balance Sheet Decomposition
Piramal Pharma Ltd
Piramal Pharma Ltd
| Current Assets | 53.8B |
| Cash & Short-Term Investments | 4.5B |
| Receivables | 18.3B |
| Other Current Assets | 31B |
| Non-Current Assets | 98.6B |
| Long-Term Investments | 2.5B |
| PP&E | 49.2B |
| Intangibles | 41.8B |
| Other Non-Current Assets | 5.1B |
Balance Sheet
Piramal Pharma Ltd
Piramal Pharma Ltd
Currency: INR
Millions
Annual
| Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
1 523
|
903
|
3 076
|
3 568
|
|
| Cash |
56
|
56
|
1 120
|
3 568
|
|
| Cash Equivalents |
1 467
|
847
|
1 956
|
0
|
|
| Short-Term Investments |
1 003
|
645
|
4 309
|
1 447
|
|
| Total Receivables |
8 504
|
9 950
|
21 393
|
24 620
|
|
| Accounts Receivables |
8 398
|
9 477
|
18 166
|
21 356
|
|
| Other Receivables |
106
|
473
|
3 228
|
3 265
|
|
| Inventory |
4 207
|
4 813
|
18 127
|
22 964
|
|
| Other Current Assets |
2 438
|
3 275
|
2 570
|
2 045
|
|
| Total Current Assets |
17 675
|
19 585
|
48 355
|
54 645
|
|
| PP&E Net |
13 846
|
14 652
|
44 415
|
48 160
|
|
| PP&E Gross |
13 846
|
14 652
|
44 415
|
48 160
|
|
| Accumulated Depreciation |
4 374
|
5 144
|
19 489
|
23 636
|
|
| Intangible Assets |
3 632
|
3 488
|
33 382
|
31 672
|
|
| Goodwill |
0
|
0
|
11 075
|
11 226
|
|
| Note Receivable |
6 138
|
7 917
|
12
|
940
|
|
| Long-Term Investments |
16 023
|
26 114
|
2 119
|
2 403
|
|
| Other Long-Term Assets |
253
|
327
|
5 868
|
4 073
|
|
| Other Assets |
0
|
0
|
11 075
|
11 226
|
|
| Total Assets |
57 567
N/A
|
72 083
+25%
|
145 226
+101%
|
153 118
+5%
|
|
| Liabilities | |||||
| Accounts Payable |
5 841
|
6 152
|
11 927
|
15 384
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1 594
|
|
| Short-Term Debt |
0
|
0
|
13 023
|
11 714
|
|
| Current Portion of Long-Term Debt |
1 669
|
6 562
|
8 493
|
9 370
|
|
| Other Current Liabilities |
7 207
|
2 457
|
4 987
|
5 631
|
|
| Total Current Liabilities |
14 717
|
15 171
|
38 431
|
43 693
|
|
| Long-Term Debt |
74
|
4 552
|
34 855
|
26 017
|
|
| Deferred Income Tax |
1 704
|
1 575
|
2 193
|
2 292
|
|
| Other Liabilities |
66
|
111
|
2 012
|
2 002
|
|
| Total Liabilities |
16 561
N/A
|
21 410
+29%
|
77 491
+262%
|
74 004
-4%
|
|
| Equity | |||||
| Common Stock |
9 946
|
11 859
|
11 933
|
13 230
|
|
| Retained Earnings |
0
|
0
|
13 631
|
14 048
|
|
| Additional Paid In Capital |
0
|
0
|
38 187
|
47 249
|
|
| Other Equity |
31 060
|
38 814
|
3 984
|
4 587
|
|
| Total Equity |
41 006
N/A
|
50 673
+24%
|
67 735
+34%
|
79 114
+17%
|
|
| Total Liabilities & Equity |
57 567
N/A
|
72 083
+25%
|
145 226
+101%
|
153 118
+5%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
1 186
|
1 186
|
1 217
|
1 323
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
